Content Tag: drug discovery

  • Rethink your Impurity Analysis Strategy

Rethink your Impurity Analysis Strategy

, , , , |

In this webinar, Dr. Ejvind Mørtz discusses the benefits and applications of mass spectrometry (MS)-based host cell protein (HCP) analysis and why HCP ELISAs are insufficient for documenting product-related impurities. Watch to learn where to apply the assay in a typical process and what you gain from deploying it to your workflow.

  • Cancer cells

Combination Therapy for Cancer Treatment

News, Scientific Articles|

The combination of anti-cancer drugs, or combination therapy, has been hailed as a “cornerstone of cancer therapy” since it targets key pathways synergistically, thereby enhancing efficacy compared to monotherapies. This blog takes a look at a recent publication in Nature, which reported the effects of 2025 pairwise drug combinations in breast, colon, and pancreatic cell lines.

  • Research Technology & Innovations Summits 2022_FI

Research Technology & Innovation Summits

The 2022 InsideScientific Research Technology & Innovation Summits focus on specific research and therapeutic areas, reviewing how novel technologies and innovative services are advancing discovery in each particular field.

  • Cutting Edge Conversation: Challenges in Sourcing Human Biosamples

Cutting Edge Conversations: Challenges in Sourcing Human Biosamples

, , |

Richard Kondo, McLean Collins, and Cathie G. Miller highlighted Episode 3 of the Cutting Edge Conversations series focused on innovations in the area of sourcing human biosamples for research. The event focused on sourcing human samples for research, including the value and necessity of working with human tissue during drug discovery, as well as some of the distinct challenges researchers face.

Go to Top